Sectors & Industries HealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2025)
Top pharmaceutical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best pharmaceutical stocks to buy now. Learn More.

Industry: Drug Manufacturers - Spec...

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Pharmaceutical is Zen Rated B and is the 34th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PAHC	PHIBRO ANIMAL HEALTH CORP	$1.16B	12.40%	2.80%	7.74%	5.90%	3.95	2.91	31.70%	2.70%	6.83%
AMRX	AMNEAL PHARMACEUTICALS INC	$2.78B	-3.00%	0.10%	12.55%	8.20%	-31.53	1.43	37.70%	0.10%	10.19%
INDV	INDIVIOR PLC	$2.78B	-56.00%	8.90%	64.65%	78.00%	-6.65	0.90	84.00%	10.90%	21.81%
ANIP	ANI PHARMACEUTICALS INC	$1.84B	-5.40%	-1.90%	-0.83%	-1.00%	2.03	2.66	59.30%	-3.40%	-1.35%
KMDA	KAMADA LTD	$422.09M	6.30%	4.40%	5.72%	14.90%	0.49	3.30	44.20%	9.60%	10.88%
SIGA	SIGA TECHNOLOGIES INC	$678.82M	40.50%	35.60%	50.40%	194.00%	0.12	10.09	76.90%	45.70%	59.65%
NBIX	NEUROCRINE BIOSCIENCES INC	$12.30B	13.20%	9.40%	15.76%	15.90%	0.44	3.20	98.50%	13.90%	21.00%
COLL	COLLEGIUM PHARMACEUTICAL INC	$1.16B	19.20%	2.90%	12.45%	18.20%	5.96	1.08	57.70%	6.60%	21.45%
IRWD	IRONWOOD PHARMACEUTICALS INC	$135.28M	N/A	-8.80%	20.72%	6.90%	-1.98	3.34	100.00%	-10.20%	18.21%
AVDL	AVADEL PHARMACEUTICALS PLC	$1.24B	-3.70%	-1.70%	3.28%	4.70%	1.06	2.79	89.60%	-1.30%	1.93%
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	$18.84B	-2.60%	-0.40%	3.19%	4.00%	4.88	1.06	49.60%	-1.00%	5.42%
ELAN	ELANCO ANIMAL HEALTH INC	$8.50B	6.70%	3.30%	6.36%	10.60%	1.03	2.60	54.70%	9.70%	17.51%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$42.49M	-12.80%	-4.40%	-5.98%	-9.20%	1.45	1.25	84.30%	-8.00%	-6.46%
VTRS	VIATRIS INC	$11.50B	-19.90%	-8.50%	-10.40%	-14.20%	1.47	1.37	36.60%	-24.60%	-23.04%
PCRX	PACIRA BIOSCIENCES INC	$1.13B	-16.50%	-8.20%	-7.18%	-7.60%	1.03	2.38	78.20%	-18.10%	-12.45%
AYTU	AYTU BIOPHARMA INC	$13.82M	5.30%	1.40%	18.88%	993.50%	2.56	1.03	68.60%	2.40%	14.59%
BHC	BAUSCH HEALTH COMPANIES INC	$2.46B	-8.90%	0.40%	8.12%	7.10%	-35.50	1.31	70.70%	1.00%	18.35%
SUPN	SUPERNUS PHARMACEUTICALS INC	$2.27B	6.20%	4.70%	7.50%	21.60%	0.30	2.58	88.50%	9.70%	12.35%
IMCC	IM CANNABIS CORP	$9.04M	-74.40%	-10.40%	-20.60%	-8.40%	7.84	0.72	18.60%	-8.10%	-1.57%
DVAX	DYNAVAX TECHNOLOGIES CORP	$1.26B	-9.80%	-6.00%	-5.55%	-4.40%	0.78	11.93	82.30%	-20.40%	-16.54%
HCM	HUTCHMED (CHINA) LTD	$2.70B	5.10%	3.00%	5.32%	6.30%	0.66	2.83	44.60%	6.00%	7.58%
ZTS	ZOETIS INC	$66.04B	53.20%	18.30%	31.70%	28.10%	1.91	1.76	71.50%	27.80%	37.54%
ETON	ETON PHARMACEUTICALS INC	$457.24M	-23.40%	-8.00%	-3.86%	-14.50%	2.44	1.97	59.40%	-9.30%	-4.59%
PRGO	PERRIGO CO PLC	$3.03B	-1.80%	-0.80%	2.92%	4.20%	1.26	2.32	35.70%	-1.90%	6.05%
DERM	JOURNEY MEDICAL CORP	$183.34M	-52.00%	-11.30%	-11.62%	-35.00%	2.94	1.34	66.50%	-14.80%	-9.24%
EBS	EMERGENT BIOSOLUTIONS INC	$442.91M	-27.30%	-9.10%	-0.07%	-0.10%	1.58	6.32	35.20%	-13.60%	-0.09%
ALKS	ALKERMES PLC	$4.38B	23.70%	16.30%	24.13%	31.70%	0.39	3.23	85.10%	23.10%	28.00%
AMPH	AMPHASTAR PHARMACEUTICALS INC	$1.29B	19.40%	9.10%	14.07%	15.90%	1.17	2.95	50.50%	19.40%	27.48%
ESPR	ESPERION THERAPEUTICS INC	$365.68M	N/A	-45.90%	-166.90%	-16.20%	-1.76	1.18	65.30%	-59.00%	-34.12%
BGM	BGM GROUP LTD	$54.99M	-2.40%	-2.10%	-3.78%	-20.90%	0.13	1.82	19.40%	-10.10%	-25.89%
ALVO	ALVOTECH	$2.57B	-23.20%	8.10%	26.10%	13.80%	-5.12	1.73	60.70%	16.40%	43.49%
TKNO	ALPHA TEKNOVA INC	$235.67M	-28.50%	-19.70%	-21.17%	-19.10%	0.45	5.64	21.00%	-60.90%	-59.19%
TAK	TAKEDA PHARMACEUTICAL CO LTD	$45.08B	1.90%	0.90%	3.77%	5.50%	1.04	1.16	64.80%	3.10%	9.96%
HLN	HALEON PLC	$43.01B	8.80%	4.20%	7.64%	20.40%	1.12	0.98	60.70%	12.80%	19.40%
QNTM	QUANTUM BIOPHARMA LTD	$91.09M	-290.00%	-163.00%	-1,290.59%	-3,068.20%	3.52	0.78	N/A	N/A	N/A
CTOR	CITIUS ONCOLOGY INC	$123.07M	-74.20%	-32.90%	-60.35%	-59.00%	1.57	0.36	N/A	N/A	N/A
HROW	HARROW INC	$1.24B	-35.80%	-6.10%	1.35%	1.10%	5.46	0.91	74.50%	-10.20%	1.12%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$3.16B	12.20%	6.40%	10.07%	23.80%	0.85	4.21	55.80%	18.90%	29.16%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$6.69B	-42.50%	-40.90%	-52.18%	-52.80%	0.03	41.92	N/A	N/A	N/A
LNTH	LANTHEUS HOLDINGS INC	$3.81B	23.60%	13.20%	21.57%	36.90%	0.81	4.29	63.70%	17.80%	26.04%
LFCR	LIFECORE BIOMEDICAL INC	$267.32M	-788.60%	-19.90%	-10.94%	-7.10%	85.36	2.71	33.40%	-37.90%	-17.34%
OGI	ORGANIGRAM GLOBAL INC	$219.49M	5.20%	3.80%	3.68%	7.00%	0.38	3.42	32.70%	8.80%	8.76%
RMTI	ROCKWELL MEDICAL INC	$32.26M	-0.90%	-0.50%	1.96%	2.60%	0.71	2.95	17.90%	-0.30%	0.86%
ORGO	ORGANOGENESIS HOLDINGS INC	$585.43M	-7.80%	-4.40%	-6.01%	-7.70%	0.41	4.12	75.90%	-4.50%	-5.27%
EVO	EVOTEC SE	$1.35B	N/A	N/A	N/A	N/A	1.13	2.03	N/A	N/A	N/A
RDY	DR REDDYS LABORATORIES LTD	$11.53B	18.40%	12.80%	21.76%	28.70%	0.47	1.92	58.50%	17.40%	24.24%
CGC	CANOPY GROWTH CORP	$292.60M	-112.80%	-52.00%	-71.78%	-51.70%	0.88	3.12	29.60%	-222.40%	-219.70%
EOLS	EVOLUS INC	$373.23M	N/A	-27.40%	-24.44%	-25.80%	-13.27	2.27	66.60%	-22.30%	-14.51%
KALA	KALA BIO INC	$46.46M	-369.30%	-65.00%	-119.60%	-154.90%	7.45	1.99	N/A	N/A	N/A
CRON	CRONOS GROUP INC	$1.03B	4.60%	4.30%	-0.12%	-0.60%	0.04	27.80	27.70%	39.70%	-1.07%
CRDL	CARDIOL THERAPEUTICS INC	$85.09M	-210.20%	-141.50%	-202.13%	580.00%	0.45	3.26	N/A	N/A	N/A
BIOA	BIOAGE LABS INC	$155.59M	-25.40%	-23.20%	-26.01%	-223.20%	0.09	13.21	100.00%	-2,045.70%	-2,015.64%
ACB	AURORA CANNABIS INC	$293.08M	-5.90%	-3.90%	-3.30%	-4.10%	0.45	2.97	47.80%	-9.10%	-6.28%
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$1.51M	-1,202.90%	-370.40%	-276.22%	-2,354.50%	0.62	2.78	N/A	N/A	N/A
AQST	AQUESTIVE THERAPEUTICS INC	$383.41M	N/A	-50.30%	-44.51%	-27.70%	-2.68	4.87	68.40%	-100.00%	-68.89%
TLRY	TILRAY BRANDS INC	$1.01B	-78.20%	-62.80%	-126.97%	-192.70%	0.39	2.46	29.30%	-266.30%	-277.34%
TLPH	TALPHERA INC	$8.61M	-129.50%	-58.90%	-89.52%	-83.50%	1.68	3.11	100.00%	-43,122.20%	-43,122.22%
DRRX	DURECT CORP	$58.05M	-94.80%	-22.70%	-81.38%	-1,352.00%	1.68	1.23	140.20%	-935.80%	-1,036.57%
CPHI	CHINA PHARMA HOLDINGS INC	$4.40M	-63.70%	-32.10%	-48.66%	-63.50%	1.04	0.56	-42.60%	-106.30%	-103.04%
SNOA	SONOMA PHARMACEUTICALS INC	$4.90M	-70.50%	-25.30%	-30.29%	-49.10%	2.10	3.09	38.20%	-24.20%	-20.35%
FLGC	FLORA GROWTH CORP	$11.92M	-298.10%	-52.00%	-146.63%	-274.80%	4.63	0.96	21.40%	-25.00%	-24.80%
AKAN	AKANDA CORP	$2.80M	-1,830.00%	-48.90%	-93.44%	1,757.10%	0.85	1.39	24.90%	-489.60%	-477.60%
BFRI	BIOFRONTERA INC	$8.66M	-216.00%	-58.50%	-191.37%	-142.60%	34.37	1.40	53.30%	-30.30%	-28.35%
EVOK	EVOKE PHARMA INC	$8.17M	-101.90%	-33.80%	-77.28%	289.90%	1.80	1.55	97.40%	-43.80%	-39.49%
APUS	APIMEDS PHARMACEUTICALS US INC	$17.71M	N/A	N/A	N/A	N/A	-1.15	0.15	N/A	N/A	N/A
ASRT	ASSERTIO HOLDINGS INC	$69.44M	-24.90%	-10.90%	-17.39%	-31.80%	1.64	1.66	69.90%	-25.70%	-23.03%
INCR	INTERCURE LTD	$79.70M	-15.90%	-8.80%	-6.19%	-7.70%	0.92	1.73	12.70%	-28.40%	-13.88%
TXMD	THERAPEUTICSMD INC	$12.50M	-7.70%	-5.40%	-6.45%	-7.20%	0.43	2.64	100.00%	-114.10%	-117.38%
PRFX	PAINREFORM LTD	$2.03M	-321.90%	-201.80%	-704.42%	1,140.50%	1.48	1.81	N/A	N/A	N/A
SXTC	CHINA SXT PHARMACEUTICALS INC	$21.81M	-22.50%	-14.80%	-16.97%	-162.40%	0.40	3.54	32,034.00%	-76,811.30%	-61,739.85%
UPC	UNIVERSE PHARMACEUTICALS INC	$2.02M	2.70%	1.70%	2.27%	5.90%	0.46	2.78	30.40%	5.60%	6.74%
RDHL	REDHILL BIOPHARMA LTD	$0.00	N/A	-40.20%	349.59%	139.50%	-4.85	0.54	60.30%	-102.80%	-181.69%
IXHL	INCANNEX HEALTHCARE INC	$13.16M	-332.20%	-144.00%	-242.50%	-406.10%	1.19	2.12	100.00%	-22,186.70%	-21,846.94%
SBFM	SUNSHINE BIOPHARMA INC	$6.52M	-21.20%	-16.90%	-22.71%	-45.20%	0.29	4.25	30.50%	-13.90%	-14.68%
SCYX	SCYNEXIS INC	$34.34M	-48.30%	-29.70%	-45.23%	-42.40%	0.34	5.83	100.00%	-1,030.00%	-1,013.99%
GELS	GELTEQ LTD	$15.29M	N/A	N/A	N/A	N/A	0.34	0.79	N/A	N/A	N/A
YCBD	CBDMD INC	$8.66M	-223.80%	-35.50%	-15.67%	-418.80%	15.43	0.63	62.40%	-21.20%	-0.85%

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Aug 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best pharma stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #1 top pharmaceutical stock out of 77 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 18 points higher than the pharmaceutical industry average of 27.

PAHC passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 65.12% over the past year, overperforming other pharmaceutical stocks by 134 percentage points.

Phibro Animal Health has an average 1 year price target of $30.50, an upside of 6.83% from Phibro Animal Health's current stock price of $28.55.

Phibro Animal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top pharmaceutical stock out of 77 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 37, which is 10 points higher than the pharmaceutical industry average of 27.

AMRX passed 12 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 17.24% over the past year, overperforming other pharmaceutical stocks by 86 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $11.50, an upside of 30.09% from Amneal Pharmaceuticals's current stock price of $8.84.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior (NASDAQ:INDV)

Indivior (NASDAQ:INDV) is the #3 top pharmaceutical stock out of 77 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior (NASDAQ:INDV) is: Value: B, Growth: C, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Indivior (NASDAQ:INDV) has a Due Diligence Score of 26, which is -1 points lower than the pharmaceutical industry average of 27. Although this number is below the industry average, our proven quant model rates INDV as a "A".

INDV passed 8 out of 33 due diligence checks and has average fundamentals. Indivior has seen its stock return 79.98% over the past year, overperforming other pharmaceutical stocks by 149 percentage points.

Indivior has an average 1 year price target of $20.75, a downside of -6.91% from Indivior's current stock price of $22.29.

Indivior stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Indivior, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 6 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Dr Reddys Laboratories (NYSE:RDY)

Dr Reddys Laboratories (NYSE:RDY) has an annual dividend yield of N/A, which is N/A percentage points lower than the pharmaceutical industry average of 2.06%. Dr Reddys Laboratories's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dr Reddys Laboratories's dividend has shown consistent growth over the last 10 years.

Dr Reddys Laboratories's dividend payout ratio of 12.2% indicates that its dividend yield is sustainable for the long-term.

2. Viatris (NASDAQ:VTRS)

Viatris (NASDAQ:VTRS) has an annual dividend yield of 3.65%, which is 2 percentage points higher than the pharmaceutical industry average of 2.06%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of -16.6% indicates that its dividend yield might not be sustainable for the long-term.

3. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) has an annual dividend yield of 2.72%, which is 1 percentage points higher than the pharmaceutical industry average of 2.06%.

Kamada's dividend payout ratio of 71.4% indicates that its dividend yield is sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 0.7% in the last day, and up 0.81% over the last week. Tilray Brands was the among the top gainers in the drug manufacturers - specialty & generic industry, gaining 41.76% yesterday.

Shares of cannabis-related stocks are trading higher following a report suggesting President Trump is considering rescheduling marijuana as a Schedule III drug that would reclassify it as a less dangerous and ease restrictions.

What are the most undervalued pharmaceutical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued pharmaceutical stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 0, which is -19 points higher than the pharmaceutical industry average of 19. It passed 0 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates IRWD a Valuation Rating of "A".

Ironwood Pharmaceuticals's stock has dropped -80.28% in the past year. It has underperformed other stocks in the pharmaceutical industry by -11 percentage points.

2. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the second most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 38 points higher than the pharmaceutical industry average of 19. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has gained 23.11% in the past year. It has overperformed other stocks in the pharmaceutical industry by 92 percentage points.

3. Emergent Biosolutions (NYSE:EBS)

Emergent Biosolutions (NYSE:EBS) is the third most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Emergent Biosolutions has a valuation score of 14, which is -5 points higher than the pharmaceutical industry average of 19. It passed 1 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates EBS a Valuation Rating of "A".

Emergent Biosolutions's stock has gained 22.34% in the past year. It has overperformed other stocks in the pharmaceutical industry by 91 percentage points.

Are pharmaceutical stocks a good buy now?

50% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 42.85% over the next year.

17.86% of pharmaceutical stocks have a Zen Rating of A (Strong Buy), 17.86% of pharmaceutical stocks are rated B (Buy), 46.43% are rated C (Hold), 12.5% are rated D (Sell), and 5.36% are rated F (Strong Sell).

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is -15.82x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.